PASG Stock Analysis: Buy, Sell, or Hold?
PASG - Passage Bio, Inc. Common Stock
$4.47
-0.02 (-0.45%)
▼
5d:
-9.51%
30d:
-2.4%
90d:
-12.52%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
7d
Get Alerted When PASG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PASG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PASG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PASG is currently trading at $4.47, which is considered oversold relative to its 30-day fair value range of $4.53 to $4.90.
Technical Outlook: Technically, PASG is in a downtrend. The price is currently testing key support at $4.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PASG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+242.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PASG is in a downtrend. The price is currently testing key support at $4.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PASG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+242.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.53 -
$4.90
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 242.9% below Wall St target ($15.50)
- CAUTION: 5-day price weakness (-9.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.53 -
$4.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.41
Resistance Level
$5.00
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.44
Wall Street Target
$15.50
(+242.9%)
Share & Embed Analysis
Last updated: August 03, 2026 2:56 AM ET
Data refreshes hourly during market hours. Next update: 3:56 AM
Data refreshes hourly during market hours. Next update: 3:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PASG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |